Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University, No 1. YouYi Road, Yuzhong District, Chongqing, 400016, China.
Cell Mol Biol Lett. 2024 Mar 14;29(1):36. doi: 10.1186/s11658-024-00558-w.
Macrophage activation may play a crucial role in the increased susceptibility of obese individuals to acute lung injury (ALI). Dysregulation of miRNA, which is involved in various inflammatory diseases, is often observed in obesity. This study aimed to investigate the role of miR-192 in lipopolysaccharide (LPS)-induced ALI in obese mice and its mechanism of dysregulation in obesity.
Human lung tissues were obtained from obese patients (BMI ≥ 30.0 kg/m) and control patients (BMI 18.5-24.9 kg/m). An obese mouse model was established by feeding a high-fat diet (HFD), followed by intratracheal instillation of LPS to induce ALI. Pulmonary macrophages of obese mice were depleted through intratracheal instillation of clodronate liposomes. The expression of miR-192 was examined in lung tissues, primary alveolar macrophages (AMs), and the mouse alveolar macrophage cell line (MH-S) using RT-qPCR. m6A quantification and RIP assays helped determine the cause of miR-192 dysregulation. miR-192 agomir and antagomir were used to investigate its function in mice and MH-S cells. Bioinformatics and dual-luciferase reporter gene assays were used to explore the downstream targets of miR-192.
In obese mice, depletion of macrophages significantly alleviated lung tissue inflammation and injury, regardless of LPS challenge. miR-192 expression in lung tissues and alveolar macrophages was diminished during obesity and further decreased with LPS stimulation. Obesity-induced overexpression of FTO decreased the m6A modification of pri-miR-192, inhibiting the generation of miR-192. In vitro, inhibition of miR-192 enhanced LPS-induced polarization of M1 macrophages and activation of the AKT/ NF-κB inflammatory pathway, while overexpression of miR-192 suppressed these reactions. BIG1 was confirmed as a target gene of miR-192, and its overexpression offset the protective effects of miR-192. In vivo, when miR-192 was overexpressed in obese mice, the activation of pulmonary macrophages and the extent of lung injury were significantly improved upon LPS challenge.
Our study indicates that obesity-induced downregulation of miR-192 expression exacerbates LPS-induced ALI by promoting macrophage activation. Targeting macrophages and miR-192 may provide new therapeutic avenues for obesity-associated ALI.
巨噬细胞激活可能在肥胖个体易患急性肺损伤(ALI)方面发挥关键作用。miRNA 失调参与各种炎症性疾病,在肥胖症中经常观察到。本研究旨在探讨 miR-192 在肥胖小鼠脂多糖(LPS)诱导的 ALI 中的作用及其在肥胖症中的失调机制。
从肥胖患者(BMI≥30.0kg/m)和对照患者(BMI 18.5-24.9kg/m)获得人肺组织。通过给予高脂肪饮食(HFD)建立肥胖小鼠模型,然后通过气管内滴注 LPS 诱导 ALI。通过气管内滴注氯膦酸盐脂质体耗尽肥胖小鼠的肺巨噬细胞。使用 RT-qPCR 检测肥胖小鼠肺组织、原代肺泡巨噬细胞(AMs)和小鼠肺泡巨噬细胞系(MH-S)中 miR-192 的表达。m6A 定量和 RIP 测定有助于确定 miR-192 失调的原因。使用 miR-192 agomir 和 antagomir 研究其在小鼠和 MH-S 细胞中的功能。生物信息学和双荧光素酶报告基因测定用于探索 miR-192 的下游靶标。
在肥胖小鼠中,无论 LPS 挑战如何,耗尽巨噬细胞均可显著减轻肺组织炎症和损伤。肥胖时肺组织和肺泡巨噬细胞中 miR-192 的表达减少,LPS 刺激后进一步降低。肥胖诱导的 FTO 过表达降低了 pri-miR-192 的 m6A 修饰,抑制了 miR-192 的产生。体外,抑制 miR-192 增强了 LPS 诱导的 M1 巨噬细胞极化和 AKT/NF-κB 炎症途径的激活,而过表达 miR-192 则抑制了这些反应。BIG1 被确认为 miR-192 的靶基因,其过表达抵消了 miR-192 的保护作用。在体内,当 miR-192 在肥胖小鼠中过表达时,LPS 挑战后肺巨噬细胞的激活和肺损伤程度显著改善。
我们的研究表明,肥胖诱导的 miR-192 表达下调通过促进巨噬细胞激活加剧 LPS 诱导的 ALI。靶向巨噬细胞和 miR-192 可能为肥胖相关 ALI 提供新的治疗途径。